British Nasaleze Nasal Spray (Nuoshu Yi)
l Comprehensively prevent and alleviate the allergic symptoms caused by inhalants such as pollen
l Effectively curb the atmospheric pollution caused by PM2.5 and other particles
l In Europe, it is a Class I medical device, and in China it belongs to Class III medical devices. Class I medical device in Europe, Class III medical device in China
British Nasaleze Nasal Spray (Nosuyi) can form a layer of protective gel film on the inner wall of the nasal cavity to reduce the inhalation of allergens and other fine particles, thus preventing and alleviating the symptoms caused by allergic reactions.
This product is pure natural plant cellulose and does not contain any pharmaceutical ingredients or preservatives.
Composition: Natural inert hydroxypropyl methylcellulose powder
Device: Rapidly delivered through a new patented method
Part of action: Localized action on the nasal cavity, including the nasal vestibule, the inner turbinates, tonsils, adenoids, etc.
Frequency of use: Recommended to be used at least 3 times a day, and multiple times as needed to accelerate the relief of symptoms
Country of origin: UK
Nasaleze Nasal Spray is a medical device that forms its own physical barrier to protect the nasal cavity without any pharmacological or chemical effects.
British Nasaleze Nasal Spray (NOS) mechanism
Powder enters the nasal cavity and reacts with water vapor to form a mucus-like gel with a pore size of nanometers on the surface of the nasal mucous membrane, which blocks airborne allergens, such as pollen, dust mites, animal dander, and fine particles such as PM2.5 from entering the organism, and the organism's own defense mechanism to play a role in the body together.
Improvement of Quality of Life (QOL) in Adults and Children with Allergic Rhinitis
l Open, Non-Competitive Clinical Study
l 25 Adults and 23 Children
l Perennial Allergic Rhinitis
l Patient Weekly Checkups for 4 Weeks
l Children Accompanied by Parent
l One Spray in Each Nostril QOL questionnaires completed at weeks 1 and 4
l Patient kept diary
Results
l Nosuquel powder reduced the severity of AR symptoms even in the first week of treatment
l Safe and effective in preventing and treating allergic rhinitis in adults and children
l None Adverse effects reported
l Double improvement in quality of life